Israeli pharmaceutical company BiolineRX Ltd. reports a successful pretrial of its BL-8020 drug, which is designed to orally treat Hepatitis C. The company has announced that due to the success of the pretrial, it will launch human trials during the first quarter of 2013.
Related posts
Red Algae Can Treat Wounds And Infections
January 26, 2023
Freight Planner Lists on Nasdaq And Raises $80M
January 26, 2023
$6M Investment For “Lettuce Milk” Startup
January 25, 2023
Israel Has World’s Best Value Internet
January 25, 2023
Facebook comments